$101 million XPRIZE Healthspan competition advances 20 teams to finals with UCSD named as testing hub
Twenty finalist teams have advanced in the $101 million XPRIZE Healthspan competition, including groups developing treatments aimed at slowing age-related decline. Ten Milestone 2 Awardees will each receive $1 million and testing support as they prepare clinical trials focused on muscle, brain and immune function. The competition runs through 2030, when a grand prize of up to $81 million will go to teams that can demonstrate major gains in healthy human aging. Salt Lake City became the center of a global race against age-related decline as XPRIZE announced 20 finalist teams pursuing treatments designed to help people stay stronger, sharper and healthier for longer. Ten of those finalists, spanning the United States, South Korea, Japan and China, were named Milestone 2 Awardees. Each receives $1 million, along with access to clinical testing resources, as the $101 million XPRIZE Healthspan competition moves toward human trials and its 2030 finale. The seven-year competition began in 2023 with more than 600 applicants. Teams are being challenged to develop treatments that restore muscle, cognitive and immune function in adults …






